Renée Galá Joins Dexcom Board of Directors

Share This Post

Key Highlights

  • Renée Galá appointed to Dexcom’s Board of Directors, effective March 6, 2025.
  • Brings extensive financial, strategic, and operational leadership experience in the life sciences sector.
  • Currently serves as President & COO at Jazz Pharmaceuticals, overseeing global business operations.
  • Strong track record in financial leadership, international expansion, and business development at high-growth companies.

Source: Business Wire

Notable Quote

  • “We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom

Why This Matters

  • “We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom

More To Explore

Total
0
Share